This volume examines the various challenges in access to health issues and the role of intellectual property rights in access to drugs as well as the scope for using traditional medicine in public health. The volume examines the Health Impact Fund, a mechanism proposed to incentivize research and development in neglected diseases and enhance access to drugs. It also analyzes how China and India can cooperate in the traditional medicine sector: providing reviews on the status of traditional medicine in both countries, the challenges of regulating that sector in China and India, intellectual property rights, and industrial policy. This is a unique collection of research essays that makes a significant contribution to the debates about access to medicine and role of traditional medicine in public health. A team of experts from China, India, UK, Germany, the Netherlands, Norway, and the Philippines have contributed to the volume and include Fatima Alvarez-Castillo, Rosa Cordillera Castillo, David Coles, Lynn J. Frewer, T. C. James, Jing Liu, Jon Pedersen, Wu Qunhong, K. Satyanarayana, Sun Xiaoyun, Liu Yan, Li Zhe, and Gao Zhiqian.
Recenzijas
This volume offers much food for thought and makes a valuable contribution to the literature. I hope that academics, policy makers and others involved in making health more accessible and affordable will find this volume relevant in their work"". - A.P.J. Abdul Kalam Former President of India
|
List of Tables, Figures and Annexures |
|
|
9 | (2) |
About the Editors/Contributors |
|
11 | (8) |
Foreword |
|
19 | (4) |
|
Preface |
|
23 | (4) |
|
Introduction: Health Sector Challenges, Traditional Medicines and India China Collaboration |
|
27 | (6) |
|
|
|
Section I Health Impact Fund |
|
|
|
1 The Health Impact Fund: Issues and Challenges |
|
|
33 | (18) |
|
|
|
2 Stakeholder Views Regarding the Objectives and Implementation of the HIF |
|
|
51 | (20) |
|
|
|
3 Health Impact of New Pharmaceutical Products in the Context of Health Impact Funds |
|
|
71 | (14) |
|
|
|
4 Gender-based Barriers to Access to Health Care and Medicine: The Case of India and China |
|
|
85 | (44) |
|
|
|
|
|
5 Intellectual Property Rights and Traditional Chinese Medicine: The Experience in China and What India can learn from that |
|
|
129 | (42) |
|
|
6 Dynamics of Traditional Medicine Industry: Issues in Trade, Technology and Standards |
|
|
171 | (46) |
|
|
7 Regulatory Guidelines for Traditional Medicines in India |
|
|
217 | (24) |
|
|
8 Traditional Medicine and Intellectual Property Policies |
|
|
241 | (40) |
|
|
|
|
9 China-India Cooperation on Intellectual Property Protection of Traditional Medicines |
|
|
281 | (12) |
|
|
10 Industrial Development: External Trade and R&D of Traditional Chinese Medicine |
|
|
293 | (14) |
|
|
11 Traditional Drug: Standard and Basic Medicine System of China |
|
|
307 | (16) |
|
|
|
12 Public Health Problem and Development of Traditional Medicine |
|
|
323 | (14) |
|
|
|
|
|
13 Potential for China-India Cooperation and HIF: Concluding Remarks and Policy Recommendations |
|
|
337 | |
|
|
Sachin Chaturvedi is a Senior Fellow at the Research and Information System for Developing Countries (RIS), a think tank with the Government of Indias Ministry of External Affairs. He works on, inter alia, development cooperation policies and South-South cooperation, and science, technology and innovation policies.
Miltos Ladikas currently holds Research Fellow posts at the Centre for Professional Ethics, University of Central Lancashire, UK and the Institute for Technology Assessment and Systems Analysis, Karlsruhe Institute of Technology, Germany. His professional background covers the areas of technology assessment, public perceptions of S&T, ethics in S&T policy and science and development.
Guo Lifeng is Associate Professor, Chinese Academy of Science and Technology for Development (CASTED), Ministry of Science and Technology, Beijing, China. Her research interests include science and technology polices and IPR issue in International trade.
Krishna Ravi Srinivas is an Associate Fellow with RIS, a policy research think tank based in New Delhi, India. He has written on, inter alia, IPRs, open source and open innovation models, traditional knowledge, and climate change and technology transfer.